Indian J Surg. 2015 Dec;77:385-92. doi: 10.1007/s12262-013-0850-3. Epub 2013 Feb 21.
A Clinical Study Comparing Helicoll with Scarlet Red and OpSite in the Treatment of Split Thickness Skin Graft Donor Sites-A Randomized Controlled Trial.
The Indian journal of surgery
Prema Dhanraj
Affiliations
Affiliations
- Department of Plastic Surgery, University of Texas Medical Branch/Shriners, Galveston, TX 77550 USA ; Department of Plastic & Reconstructive Surgery, Christian Medical College (CMC) Hospital, Vellore, 632 004 Tamil Nadu India ; 58/1 Banashankari Extn, 13th main, J.P. Nagar, 1st phase, Bangalore, KA 560078 India.
PMID: 26730031
PMCID: PMC4692922 DOI: 10.1007/s12262-013-0850-3
Abstract
Split thickness skin graft (STSG) is a key method in the reconstructive ladder for covering skin defects used widely by surgeons from all specialties. The donor site is often a source of delayed healing, associated with considerable pain and discomfort even more than the recipient wound. The aim of this prospective randomized controlled study was to compare Helicoll® (EnColl Corp., Fremont, CA, USA), a type I pure collagen dressing, to OpSite® (Smith & Nephew, USA) dressing and to Scarlet Red® (Kendall HealthCare, USA) dressing in the treatment of standardized STSG donor sites. Thirty patients, over a 3-month period, underwent various reconstructive procedures, necessitating the use of STSGs. Following a simple randomized clinical protocol, the analysis of data included donor site pain, healing time of the donor site, initial absorption of the applied dressing and rate of infection with the three different dressings to form the basis of this paper. Patients in the Helicoll group reported significantly less pain, less infection rate and required no dressing change when compared with the OpSite (Johnson & Johnson, Langhorne, PA, USA) or the Scarlet Red groups. Healing time of the donor site in the Helicoll group was shorter than that in the Scarlet Red group; however, it was comparable to the OpSite group. This study indicates that Helicoll, as a donor site dressing, is successful in providing pain-free mobility with a measurable healing rate.
Keywords: Donor site; Helicoll; OpSite; Scarlet Red; Split thickness skin graft (STSG)
References
- Br J Nurs. 1998 Mar 26-Apr 8;7(6):324-6, 328, 330 passim - PubMed
- J Trauma. 1974 Feb;14(2):163-7 - PubMed
- Arch Surg. 1973 May;106(5):705-6 - PubMed
- Ann Plast Surg. 1980 Sep;5(3):238-43 - PubMed
- Arch Surg. 1985 Jun;120(6):743-5 - PubMed
- Scand J Plast Reconstr Surg Hand Surg. 1998 Dec;32(4):407-13 - PubMed
- Plast Reconstr Surg. 1979 Jul;64(1):112-4 - PubMed
- Burns. 1992 Apr;18(2):145-8 - PubMed
- Br J Plast Surg. 1993 Jan;46(1):79-81 - PubMed
- Dermatol Nurs. 1996 Jun;8(3):174-6, 204 - PubMed
- Br J Plast Surg. 1989 Jul;42(4):373-9 - PubMed
- Ann Plast Surg. 1991 Sep;27(3):288-91 - PubMed
- Burns Incl Therm Inj. 1989 Feb;15(1):7-10 - PubMed
- Br J Plast Surg. 1975 Apr;28(2):107-10 - PubMed
- J Invest Dermatol. 1992 Dec;99(6):729-33 - PubMed
- J Pediatr Surg. 1984 Dec;19(6):846-7 - PubMed
- Br J Plast Surg. 1991 May-Jun;44(4):247-9 - PubMed
- J Wound Care. 1995 Sep;4(8):366-7; discussion 368-71 - PubMed
- Burns Incl Therm Inj. 1983 Nov;10(2):94-103 - PubMed
- Surg Gynecol Obstet. 1991 Jul;173(1):1-5 - PubMed
- Ann Plast Surg. 2001 Apr;46(4):409-14 - PubMed
- Plast Reconstr Surg. 1978 Feb;61(2):275-6 - PubMed
- Scand J Plast Reconstr Surg Hand Surg. 2000 Mar;34(1):55-9 - PubMed
- Arch Otolaryngol Head Neck Surg. 1995 Oct;121(10):1145-9 - PubMed
- Am J Surg. 1983 Mar;145(3):379-81 - PubMed
- Scand J Plast Reconstr Surg. 1976;10(3):237-40 - PubMed
- J Burn Care Rehabil. 1987 Sep-Oct;8(5):384-6 - PubMed
- J Burn Care Rehabil. 1995 Jan-Feb;16(1):59-61 - PubMed
- Ann Plast Surg. 2001 Apr;46(4):405-8 - PubMed
- Burns. 2001 Sep;27(6):621-7 - PubMed
- Br J Plast Surg. 1991 Jan;44(1):55-6 - PubMed
- J Burn Care Rehabil. 1994 Jul-Aug;15(4):359-63 - PubMed
Publication Types